| Zeit | Aktuelle Nachrichten
| | Leser | Medien |
|---|
| 22.05.
| Haemonetics to Present at the Jefferies 2012 Global Healthcare Conference | | 7 | PR Newswire |
| BRAINTREE, Mass., May 22, 2012 /PRNewswire/ --Haemonetics Corporation (NYSE: HAE) announced today that Chris Lindop, CFO and VP, Business Development, will present at the Jefferies 2012...
Mehr lesen zu:
Haemonetics to Present at the Jefferies 2012 Global Healthcare Conference | |
| 08.05.
| Haemonetics Releases Next Generation of IMPACT® Online Blood Utilization Portal | | 9 | PR Newswire |
| BRAINTREE, Mass., May 8, 2012 /PRNewswire/ --Haemonetics Corporation (NYSE: HAE) announced today that it has released the next generation of its blood management intelligence portal - IMPACT® Online...
Mehr lesen zu:
Haemonetics Releases Next Generation of IMPACT® Online Blood Utilization Portal | |
| 07.05.
| Will Haemonetics' Next Quarter Be a Bomb? | | 2 | Motley Fool |
| 03.05.
| Haemonetics to Present at Bank of America Merrill Lynch 2012 Health Care Conference | | 42 | PR Newswire |
| BRAINTREE, Mass., May 3, 2012 /PRNewswire/ --Haemonetics Corporation (NYSE: HAE) announced today that Chris Lindop, CFO and VP, Business Development, will present at the Bank of America Merrill Lynch...
Mehr lesen zu:
Haemonetics to Present at Bank of America Merrill Lynch 2012 Health Care Conference | |
| 02.05.
| Upgrade Alert for Haemonetics | | 1 | SmarTrend |
| 01.05.
| Morgan Stanley stuft Haemonetics von underweight auf equal weight | | 71 | BörseGo |
| Morgan Stanley stuft Haemonetics von underweight auf equal weight
(© BörseGo AG 2012 - Autor: Tobias Krieg, Redakteur)
Mehr lesen zu:
Morgan Stanley stuft Haemonetics von underweight auf equal weight | |
| 30.04.
| Haemonetics Rev Up, Eyes Acquisition | | 1 | Zacks |
| 30.04.
| Haemonetics Shares Climbing Higher, Up 4.5% | | - | SmarTrend |
| 29.04.
| Pall to sell blood collection assets to Haemonetics | | 1 | Reuters.com |
| 29.04.
| Pall To Sell Blood Collection, Filtration/Processing Lines To Haemonetics | | 146 | AFX News |
| WASHINGTON (dpa-AFX) - Pall Corp. (PLL) announced that it has entered into
an agreement to sell certain assets of its blood collection, filtration and
processing product lines to Haemonetics...
Mehr lesen zu:
Pall To Sell Blood Collection, Filtration/Processing Lines To Haemonetics | |
| 29.04.
| Pall Corporation Signs Definitive Agreement to Sell its Blood Collection, Filtration and Processing Product Lines to Haemonetics for $550M | | 2 | Benzinga.com |
| 29.04.
| Haemonetics Reports 10% Revenue Growth for Fourth Quarter of Fiscal 2012 and $0.80 Adjusted EPS; Also Establishes Fiscal 2013 Guidance | | 95 | PR Newswire |
| BRAINTREE, Mass., April 29, 2012 /PRNewswire/ --Haemonetics Corporation (NYSE: HAE) today reported fourth quarter 2012 GAAP net revenue of $186.7 million, up 10%, net income of $17.8...
Mehr lesen zu:
Haemonetics Reports 10% Revenue Growth for Fourth Quarter of Fiscal 2012 and $0.80 Adjusted EPS; Also Establishes Fiscal 2013 Guidance | |
| 29.04.
| Haemonetics Changes Timing of Fourth Quarter and Year End Fiscal Year 2012 Webcast: April 30, 2012 at 8:00 am Eastern Time | | 75 | PR Newswire |
| BRAINTREE, Mass., April 29, 2012 /PRNewswire/ --Haemonetics Corporation (NYSE: HAE) announced that it will conduct its April 30, 2012 webcast at 8:00 am (EDT), two hours earlier than previously announced....
Mehr lesen zu:
Haemonetics Changes Timing of Fourth Quarter and Year End Fiscal Year 2012 Webcast: April 30, 2012 at 8:00 am Eastern Time | |
| 29.04.
| Haemonetics Signs Definitive Agreement To Acquire Hemerus Medical, LLC | | 73 | PR Newswire |
| BRAINTREE, Mass., April 29, 2012 /PRNewswire/ --Haemonetics Corporation (NYSE: HAE) announced that it has entered into a definitive agreement to acquire the business assets of Hemerus Medical, LLC...
Mehr lesen zu:
Haemonetics Signs Definitive Agreement To Acquire Hemerus Medical, LLC | |
| 29.04.
| Pall Corporation Signs Definitive Agreement to Sell its Blood Collection, Filtration and Processing Product Lines to Haemonetics for $550 Million | | 91 | Business Wire |
| Pall Corporation (NYSE:PLL) today announced it has entered into an
agreement to sell certain assets of its blood collection, filtration and
processing product lines to...
Mehr lesen zu:
Pall Corporation Signs Definitive Agreement to Sell its Blood Collection, Filtration and Processing Product Lines to Haemonetics for $550 Million | |
| 29.04.
| Haemonetics Signs Definitive Agreement to Acquire Pall Corporation's Blood Collection, Filtration and Processing Product Lines For $551 Million | | 92 | PR Newswire |
| BRAINTREE, Mass., April 29, 2012 /PRNewswire/ --Haemonetics Corporation (NYSE: HAE) has entered into a definitive agreement to acquire the business assets of the blood collection, filtration and processing...
Mehr lesen zu:
Haemonetics Signs Definitive Agreement to Acquire Pall Corporation's Blood Collection, Filtration and Processing Product Lines For $551 Million | |
| 05.04.
| Haemonetics Sets Date for Fourth Quarter and Year End Fiscal Year 2012 Earnings Release: April 30, 2012 | | 22 | PR Newswire |
| BRAINTREE, Mass., April 5, 2012 /PRNewswire/ --Haemonetics Corporation (NYSE: HAE) will announce its earnings for the fourth quarter and full fiscal year 2012ended March 31, 2012and will provide guidance...
Mehr lesen zu:
Haemonetics Sets Date for Fourth Quarter and Year End Fiscal Year 2012 Earnings Release: April 30, 2012 | |
| 03.04.
| Shares of Haemonetics Rise to a New 52-Week High | | - | SmarTrend |
| 09.03.
| Haemonetics Sets Date for Investor/Analyst Meeting | | 12 | PR Newswire |
| BRAINTREE, Mass., March 9, 2012 /PRNewswire/ --Haemonetics Corporation (NYSE: HAE) announced today that it will host its annual investor and analyst day on Thursday, May 10th from 10:00 am to 12:30...
Mehr lesen zu:
Haemonetics Sets Date for Investor/Analyst Meeting | |
| 24.02.
| Dave Helsel Joins Haemonetics as Vice President of Global Manufacturing | | 27 | PR Newswire |
| BRAINTREE, Mass., Feb.24, 2012 /PRNewswire/ --Haemonetics Corporation (NYSE:HAE) announced that David D. Helsel will join the Company effective March 5, 2012 as Vice President of Global...
Mehr lesen zu:
Dave Helsel Joins Haemonetics as Vice President of Global Manufacturing | |
